4//SEC Filing
ORCHID CELLMARK INC 4
Accession 0001181431-11-061153
CIK 0001107216operating
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 4:53 PM ET
Size
11.9 KB
Accession
0001181431-11-061153
Insider Transaction Report
Form 4
BOLOGNA THOMAS A
DirectorPresident and CEO
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2011-12-15$2.80/sh−170,000$476,000→ 0 totalExercise: $1.64Exp: 2020-05-26→ Common Stock (170,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2011-12-15$2.80/sh−145,000$406,000→ 0 totalExercise: $3.03Exp: 2018-06-05→ Common Stock (145,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2011-12-15$2.80/sh−600,000$1,680,000→ 0 totalExercise: $4.53Exp: 2016-04-25→ Common Stock (600,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2011-12-15$2.80/sh−170,000$476,000→ 0 totalExercise: $1.54Exp: 2019-06-25→ Common Stock (170,000 underlying)
Footnotes (3)
- [F1]This option was cancelled pursuant to the Agreement and Plan of Merger between Laboratory Corporation of America Holdings, OCM Acquisition Corp. and Orchid Cellmark Inc., dated as of April 5, 2011, as amended (the "Merger Agreement"). The reporting person did not receive any consideration for the cancellation because the exercise price of the options was more than the offer price ($2.80 per share).
- [F2]This option was cancelled in exchange for a cash payment of $214,200, representing the difference between the exercise price of the option and the offer price ($2.80 per share) pursuant to the Merger Agreement.
- [F3]This option was cancelled in exchange for a cash payment of $197,200, representing the difference between the exercise price of the option and the offer price ($2.80 per share) pursuant to the Merger Agreement.
Documents
Issuer
ORCHID CELLMARK INC
CIK 0001107216
Entity typeoperating
Related Parties
1- filerCIK 0001107216
Filing Metadata
- Form type
- 4
- Filed
- Dec 18, 7:00 PM ET
- Accepted
- Dec 19, 4:53 PM ET
- Size
- 11.9 KB